Table 3 Costs of all pharmaceuticals used by patients treated for COPD in Denmark 2016

All pharmaceuticals, total (A00-V20)

93,208

1,383

100

81,942

1,876

100

1.28(1.28–1.28)

Respiratory organs (R* & V01)

52,768

783

56.6

45,009

1,030

54.9

1.21(1.21–1.22)

Coagulation or blood (B*)

5,795

86

6.2

6,087

139

7.4

1.49(1.49–1.49)

Neurology or psychiatry (N03-99)

6,515

97

7.0

5,824

133

7.1

1.47(1.47–1.47)

Pain, muscles, joints (N00-02 & M01-09^c)

5,358

79

5.7

5,142

118

6.3

1.47(1.47–1.48)

Diabetes (A10)

4,543

67

4.9

3,808

87

4.6

1.32(1.32–1.32)

Hypertension or heart (C00-09^b)

4,123

61

4.4

3,523

81

4.3

1.24(1.24–1.24)

Other digestive system (A00-16^d)

2,602

39

2.8

2,946

67

3.6

1.64(1.63–1.64)

Infection (J* & P*)

2,178

32

2.3

2,669

61

3.3

1.80(1.79–1.80)

Thyroid and not-sex hormones (H*)

1,299

19

1.4

1,408

32

1.7

1.59(1.58–1.59)

Urologic disease (G04)

1,531

23

1.6

1,048

24

1.3

1.00(0.99–1.00)

Hyperlipidaemia (C10)

1,749

26

1.9

1,028

24

1.3

0.91(0.91–0.91)

Eyes and ears (S*)

1,123

17

1.2

785

18

1.0

0.97(0.97–0.97)

Gastric acid (A02)

716

11

0.8

601

14

0.7

1.26(1.25–1.26)

Female organs or hormones (G01-03)

923

14

1.0

528

12

0.6

0.86(0.85–0.86)

Dermatology (D*)

702

10

0.8

525

12

0.6

1.11(1.11–1.12)

Osteoporosis (M05)

530

8

0.6

514

12

0.6

1.37(1.36–1.38)

Neoplasms or immune system (L*)

309

5

0.3

120

3

0.1

0.59(0.59–0.60)

Others

444

7

0.5

377

9

0.5

1.41(1.40–1.41)